Emerging Trends and Growth Opportunities in the Digital PCR Market

-

The global digital PCR market is projected to reach USD 12.4 billion by 2028, growing at a CAGR of 7.8% from USD 8.5 billion in 2023. This growth is driven by factors such as the increasing incidence of infectious diseases and genetic disorders, advancements in PCR technologies, and rising investments in the field. The qPCR reagents and consumables segment holds the largest market share, supported by the automation and miniaturization of instruments, advanced software, and customized laboratory reagents.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204

Reagents and consumables for qPCR and dPCR hold the largest market share in the global dPCR and qPCR market. The qPCR reagents and consumables segment is expected to dominate the market in 2023. Researchers and healthcare professionals increasingly utilize dPCR and qPCR products due to automation and miniaturization of instruments, advanced software, and customized laboratory reagents. The adoption of MIQE guidelines globally is also driving the use of qPCR and dPCR reagents. The expanding applications of qPCR, with its technological advantages over traditional PCR, such as real-time analysis and reduced analysis time, are expected to fuel the growth of the reagents and consumables market.

In terms of application, the clinical segment holds the largest share in the qPCR and dPCR market. It is estimated to dominate the market during the forecast period. Factors driving this growth include the growing usage of qPCR in disease diagnosis, increasing incidence of infectious and genetic diseases, and the emphasis on early and effective disease diagnosis and treatment.

Similarly, in the digital PCR (dPCR) market, the clinical applications segment is expected to hold the largest share in 2022. The technological benefits offered by dPCR over qPCR and traditional PCR, such as high flexibility, increased device sensitivity, better precision, and absolute quantification of target molecules, drive its adoption in hospitals, diagnostic centers, and research institutions. The increasing global burden of cancer and AIDS further contributes to the growth of the clinical applications segment. Factors such as growing usage of qPCR in disease diagnosis, rising incidence of infectious and genetic diseases, and the emphasis on early and effective disease diagnosis and treatment also drive the market growth of the clinical applications segment.

Get 10% Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=174151204

North America leads the dPCR and qPCR market, followed by Europe, due to factors like the adoption of innovative genomic analysis products, research funding, and widespread use of PCR techniques in clinical diagnostics and forensics. Key players in the market include Thermo Fisher Scientific, Danaher Corporation, and F. Hoffmann-La Roche, Ltd.

Related links:

https://www.marketsandmarkets.com/Market-Reports/digital-pcr-market-174151204.html

https://www.marketsandmarkets.com/PressReleases/digital-pcr.asp

https://www.prnewswire.com/news-releases/digital-pcr-dpcr-and-real-time-pcr-qpcr-market-worth-12-4-billion--marketsandmarkets-301794101.html

https://www.openpr.com/news/3052904/digital-pcr-dpcr-and-real-time-pcr-qpcr-market-worth-12-4

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in thei...
Read more

Strategies Adopted by the Major Players in this Digital PCR Market

-
 According to research report the  Digital PCR Market  is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period. Product Launches: Key Strategy Adopted by the Major Players in this Market New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market. The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluid...
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d...
Read more